Serotonin pharmacology in the gastrointestinal tract: a review

被引:0
作者
D. T. Beattie
J. A. M. Smith
机构
[1] Theravance,Pharmacology and Molecular and Cellular Biology Departments
[2] Inc,undefined
来源
Naunyn-Schmiedeberg's Archives of Pharmacology | 2008年 / 377卷
关键词
5-HT; Gastrointestinal; Enteric nervous system;
D O I
暂无
中图分类号
学科分类号
摘要
Serotonin (5-hydroxytryptamine or 5-HT) plays a critical physiological role in the regulation of gastrointestinal (GI) function. 5-HT dysfunction may also be involved in the pathophysiology of a number of functional GI disorders, such as chronic constipation, irritable bowel syndrome and functional dyspepsia. This article describes the role of 5-HT in the enteric nervous system (ENS) of the mammalian GI tract and the receptors with which it interacts. Existing serotonergic therapies that have proven effective in the treatment of GI functional disorders and the potential of drugs currently in development are also highlighted. Advances in our understanding of the physiological and pathophysiological roles of 5-HT in the ENS and the identification of selective receptor ligands bodes well for the future development of more efficacious therapies for patients with functional GI disorders.
引用
收藏
页码:181 / 203
页数:22
相关论文
共 1349 条
[1]  
Aapro M(2005)5-HT(3)-receptor antagonists in the management of nausea and vomiting in cancer and cancer treatment Oncology 69 97-109
[2]  
Abell TL(1991)Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility Dig Dis Sci 36 616-620
[3]  
Camilleri M(1993)Cloning of another human serotonin receptor (5-HT Proc Natl Acad Sci USA 90 408-412
[4]  
DiMagno EP(2004)): a fifth 5-HT Br J Pharmacol 141 S36-S37
[5]  
Hench VS(1995) receptor subtype coupled to the inhibition of adenylate cyclase Br J Cancer 72 1013-1015
[6]  
Zinsmeister AR(2006)Guide to receptors and channels Gastroenterology 130 34-43
[7]  
Malagelada JR(2000)Comparative efficacy of a single oral dose of ondansetron and of buspirone against cisplatin-induced emesis in cancer patients J Pharmacol Exp Ther 294 672-679
[8]  
Adham N(2004)Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome Eur J Pharmacol 484 127-139
[9]  
Kao HT(2005)5-Hydroxytryptamine(7) receptor activation decreases slow afterhyperpolarization amplitude in CA3 hippocampal pyramidal cells Am J Health-Syst Pharm 62 700-711
[10]  
Schechter LE(2005)Molecular cloning and pharmacological characterization of the guinea pig 5-HT1E receptor Clin Pharmacol Ther 77 583-586